GCANGreater Cannabis Co Inc.

About Greater Cannabis Co Inc. (GCAN)

Greater Cannabis Co Inc. (GCAN) is a Drug Manufacturers - Specialty & Generic company headquartered in Baltimore, MD, United States whose shares trade over-the-counter on the Pink tier.

The Greater Cannabis Company (OTC: GCAN) ("GCANRx") is a fully reporting publicly traded biopharmaceutical company focused on the development and commercialization of innovative cannabinoid therapeutics. GCANRx's mission is to bring our products to the global market through partnerships with leading cannabis and pharmaceutical companies, for the benefit of patients and consumers. More information on the Greater Cannabis Company and its technology can be found on the Company's website, www.gcanrx.com.

Products and services

The Company is focused on research and development of novel therapeutics for neuropsychiatric disorders.

GCAN key facts

Ticker symbol

GCAN

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Baltimore, MD, United States

Country of incorporation

US

Employees

2

Estimated market cap

$1.18M (as of Apr 9, 2025)

Shares outstanding

1,074,888,436

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Latest filing

8K Report (Mar 6, 2025)

Greater Cannabis Co Inc. leadership

• Aitan Zacharin — CEO, Acting CFO

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with G